about
sameAs
The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancerBrain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications.DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.Leptomeningeal metastasis of poorly differentiated uterine cervical adenosquamous carcinoma following reirradiation to metastatic vertebrae: A case reportVery late and isolated leptomeningeal relapse of a pulmonary adenocarcinoma presenting as dementia.Leptomeningeal metastases from a primary central nervous system melanoma: a case report and literature review.Ocular symptoms secondary to meningeal carcinomatosis in a patient with lung adenocarcinoma: a case report.Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?Thinprep plus Papanicolaou stain method is more sensitive than cytospin-coupled Wright Giems stain method in cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis from solid tumors.Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcomeAntiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor- and growth factor receptor-targeted approaches.Leptomeningeal Metastasis: Challenges in Diagnosis and TreatmentEpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.CNS metastasis in primary breast cancer.Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancerTreatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumabConcurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeability.Diagnosis and individualized therapy of neoplastic meningitis.Gemcitabine plus oxaliplatin for the treatment of leptomeningeal metastases of non-small cell lung cancer: A case report and review of the literature.Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis.Polyradiculopathies from schwannomatosis.Survival of breast cancer patients with meningeal carcinomatosis.Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades.Occult Breast Cancer Presenting as Leptomeningeal Carcinomatosis.Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.Breast leptomeningeal metastasis recurrence presenting as a manic episode.Leptomeningeal involvement after remission of brain metastases from ovarian cancer.Complications related to the placement of an intraventricular chemotherapy device.Gamma Knife radiosurgery for brain metastases from gastrointestinal primary.Patient outcomes of whole brain radiotherapy for brain metastases versus leptomeningeal metastases: A retrospective study.Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge.Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors.Unusual presentation of central nervous system metastases: mechanisms of spread and radiological findings.Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience.Neoplastic meningitis: How MRI and CSF cytology are influenced by CSF cell count and tumor type.Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases
P2860
Q26740529-65EE3091-067A-4608-B07E-6CD474B0117CQ31010216-4FB38EF4-7A8F-4E51-A2FE-8A2A601053C0Q33529158-E2D05B1F-D907-4870-BCB4-1ACE22ADEDE6Q33672958-07E0DDB0-39CE-48FD-BEDC-CA382BC2B01DQ33916093-E485CA30-CB21-47DD-929E-DB333CBA93C5Q34085075-39BECE0F-EF09-4C6C-9205-6581FDED02AEQ34515022-1C20223A-164E-4690-B84F-743249447CE4Q35076287-4B964AA4-B570-4B3A-ABF7-75988BC41F26Q35302108-A3301814-87A2-4DF3-ABF1-15614FF49B02Q35799389-5ACC39BE-46E9-474E-8E73-1BE2560196BBQ36397316-BC2AD2AF-BE0B-4138-B189-DB38042F8588Q36469191-54660A19-8744-4AE5-8CAB-8209DC02F529Q36893219-EE6B7BCE-CF11-4E64-966F-00DD461BA114Q37004668-BE1965CF-AB0A-4348-BB59-87EC3EA0D51DQ37108177-B8230860-33D4-4D9D-ADFA-9840F229A97AQ37289402-A86D722C-FF23-405F-B797-0ECCD8857883Q37394649-88B3D5D6-2194-423D-B916-003D03572948Q37428802-471B6013-C307-430F-B766-60D05E8F1F24Q37724215-8E7EC11C-65D0-435B-B318-15B462494CEBQ37774360-935099B5-4612-4FD0-BF17-4013823C8405Q38113963-50D1587C-2B01-4FD7-A884-A74064DF403EQ41164956-33559C64-0457-42AA-8126-19525899776CQ41593151-490F50AF-173F-42CF-BAFF-BD83B85425F1Q41956643-0530A6C0-741C-46EF-AC93-706713C2ACF1Q43079397-53C6D071-578E-4808-962C-BA9B51BC4089Q43824194-F4F47D79-28BE-41A5-BD46-5FC719A54428Q47118821-9983B3AA-33AE-4C22-B066-6A06C23D921DQ47770190-78081781-EA51-44E9-ADF6-A3A5EEB7FFB0Q47994252-4F42DF08-246D-4062-81E1-341F648B0F34Q48106298-8CC1DA0B-2CD4-497B-B7EA-E46106CB37F6Q48309590-004132BF-BC74-4C57-922F-AA28819244AFQ48332118-A2421C45-4205-49A6-BE0D-3959C25A5344Q48517377-D4A9E93D-655F-4D86-84FF-FF5E6D39F4DEQ48661237-DACD56C8-13C7-4A03-8E05-7EBBD6339E7EQ48720393-08D57754-81F1-4674-A050-AEF3CA456299Q48867370-3A36677B-3837-4B77-8556-396E14102E5EQ50893897-7C946DAD-0F28-465B-8735-FB210D653214Q54335141-3E9E7FF8-48AA-47BE-9061-AFCB79BA9014Q58780721-E1274104-FCB6-4AD4-8F2D-27A781A96D88
P2860
description
im Mai 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2005
@uk
name
Neoplastic Meningitis
@en
Neoplastic Meningitis
@nl
type
label
Neoplastic Meningitis
@en
Neoplastic Meningitis
@nl
altLabel
Neoplastic meningitis
@en
prefLabel
Neoplastic Meningitis
@en
Neoplastic Meningitis
@nl
P356
P1476
Neoplastic Meningitis
@en
Neoplastic meningitis
@en
P2093
Marc C Chamberlain
Marc C. Chamberlain
P304
P356
10.1200/JCO.2005.01.131
P407
P577
2005-05-20T00:00:00Z